192 related articles for article (PubMed ID: 16819752)
1. The need for more efficient trial designs.
Golub HL
Stat Med; 2006 Oct; 25(19):3231-5; discussion 3313-4, 3326-47. PubMed ID: 16819752
[TBL] [Abstract][Full Text] [Related]
2. Improving efficiency of ALS clinical trials using lead-in designs.
Moore DH; Miller RG
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():57-60. PubMed ID: 15512875
[TBL] [Abstract][Full Text] [Related]
3. Flexible two-stage design with sample size reassessment for survival trials.
Desseaux K; Porcher R
Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
Liu GF; Zhu GR; Cui L
Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
[TBL] [Abstract][Full Text] [Related]
5. Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA; Hux M
Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
[TBL] [Abstract][Full Text] [Related]
6. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
Li B; Grambsch P
Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
[TBL] [Abstract][Full Text] [Related]
7. Estimation in flexible two stage designs.
Brannath W; König F; Bauer P
Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
[TBL] [Abstract][Full Text] [Related]
8. Review of draft FDA adaptive design guidance.
Cook T; DeMets DL
J Biopharm Stat; 2010 Nov; 20(6):1132-42. PubMed ID: 21058109
[TBL] [Abstract][Full Text] [Related]
9. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
Liu Q; Li G; Anderson KM; Lim P
J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
[TBL] [Abstract][Full Text] [Related]
10. Adaptive methods: when and how should they be used in clinical trials?
Porcher R; Lecocq B; Vray M;
Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
[TBL] [Abstract][Full Text] [Related]
11. Economics in sample size determination for clinical trials.
Torgerson DJ; Ryan M; Ratcliffe J
QJM; 1995 Jul; 88(7):517-21. PubMed ID: 7633878
[TBL] [Abstract][Full Text] [Related]
12. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
Jahn-Eimermacher A; Hommel G
Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
[TBL] [Abstract][Full Text] [Related]
13. Strategies for including patients recruited during interim analysis of clinical trials.
Faldum A; Hommel G
J Biopharm Stat; 2007; 17(6):1211-25. PubMed ID: 18027227
[TBL] [Abstract][Full Text] [Related]
14. Group sequential and discretized sample size re-estimation designs: a comparison of flexibility.
Wu X; Cui L
Stat Med; 2012 Oct; 31(24):2844-57. PubMed ID: 22733405
[TBL] [Abstract][Full Text] [Related]
15. Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials.
Ellenberg SS
Oncology (Williston Park); 1989 Aug; 3(8):39-46; discussion 48, 51. PubMed ID: 2519197
[TBL] [Abstract][Full Text] [Related]
16. A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.
Wang J
J Biopharm Stat; 2012; 22(6):1127-36. PubMed ID: 23075012
[TBL] [Abstract][Full Text] [Related]
17. Combining proof-of-concept with dose-finding: utilization of adaptive designs in migraine clinical trials.
Sagkriotis A; Scholpp J
Cephalalgia; 2008 Aug; 28(8):805-12. PubMed ID: 18513264
[TBL] [Abstract][Full Text] [Related]
18. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
19. Optimal designs for estimating the interesting part of a dose-effect curve.
Miller F; Guilbaud O; Dette H
J Biopharm Stat; 2007; 17(6):1097-115. PubMed ID: 18027219
[TBL] [Abstract][Full Text] [Related]
20. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
van der Lee JH; Wesseling J; Tanck MW; Offringa M
J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
